Throat glucocorticoids

MANAGING INFECTION. The nurse should report any slight rise in temperature, sore throat, or other signs of infection to the primary health care provider as soon as possible because of a possible decreased resistance to infection during glucocorticoid therapy. Nursing personnel and visitors with any type of infection or recent exposure to an infectious disease should avoid patient contact. 

Local adverse effects are common in patients with asthma who use inhaled glucocorticoids, as suggested by a survey of the prevalence of throat and voice symptoms in patients with asthma using glucocorticoids by metered-dose pressurized aerosol (SEDA-20, 369 35). 

Topical administration to the nose The safety of nasal glucocorticoids in the treatment of allergic rhinitis has been reviewed (434,435). The local application of glucocorticoids for seasonal or perennial rhinitis often results in systemic adverse effects. The use of nasal sprays containing a glucocorticoid that has specific topical activity (such as beclomethasone dipropionate or flunisolide) seems to reduce the systemic adverse effects, but they can nevertheless occur, even to the extent of suppression of basal adrenal function in children (436). Local adverse effects include Candida infection, nasal stinging, epistaxis, throat irritation (437), and, exceptionally, anosmia (438). 

Angioedema has been reported in an obese woman after she had taken pioglitazone 30 mg/day for 7 days (130). She developed a sore throat followed by dyspnea and swelling of the lips and tongue. There was no rash. After intravenous glucocorticoids her symptoms rapidly abated. 

General anesthetics, see Anesthetics Germanium, 16.545 Glucocorticoids bone, 16.447, 22.182, 25.195 contact allergy, 15.139, 21.158 effective dose and therapeutic ratio, 23.175 and eyes, 29.481 and growth, 14.335 inhaled, children, risks in, 27.174 inhaled, effects on mouth and throat, 29.168... 

---